249 related articles for article (PubMed ID: 22439409)
1. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
[TBL] [Abstract][Full Text] [Related]
2. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
3. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
4. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
5. Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Fang J; Liu LF; Zhu JQ; Yu H
Eur J Gynaecol Oncol; 2015; 36(3):326-9. PubMed ID: 26189262
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X
Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
12. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
15. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
Zhang X; Lv Z; Lou H
BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
[TBL] [Abstract][Full Text] [Related]
18. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
19. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
20. High-grade neuroendocrine carcinoma of the cervix. A case report.
Baykal C; Al A; Tulunay G; Bulbul D; Güler G; Ozer S; Küçükali T
Gynecol Obstet Invest; 2005; 59(4):207-11. PubMed ID: 15746553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]